UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Human genetics, ISSN 0340-6717, 06/2020, Volume 139, Issue 6-7, pp. 777 - 781
Life Sciences & Biomedicine | Genetics & Heredity | Science & Technology | Genomics | Analysis | Communicable diseases | Genetic research | Disease susceptibility | Genetic aspects | Genomes | HIV (Viruses) | Hepatitis C virus | Pathogens | Genetic variance | Infectious diseases | Hepatitis C | Human immunodeficiency virus--HIV | Index Medicus
Journal Article
Nature (London), ISSN 0028-0836, 09/2009, Volume 461, Issue 7262, pp. 399 - 401
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Antiviral agents | Biological and medical sciences | Medical sciences | Pharmacology. Drug treatments | Antibiotics. Antiinfectious agents. Antiparasitic agents | Interferon-alpha - pharmacology | Far East - ethnology | Humans | Hepatitis C, Chronic - virology | Polyethylene Glycols - adverse effects | Hepatitis C, Chronic - ethnology | Recombinant Proteins | Polyethylene Glycols - therapeutic use | Europe - ethnology | Viral Load | Chromosomes, Human, Pair 19 - genetics | Interleukins - genetics | Polyethylene Glycols - pharmacology | Hepacivirus - drug effects | Genome-Wide Association Study | Hispanic Americans - genetics | Pharmacogenetics | Gene Frequency | Interferon-alpha - therapeutic use | African Americans - genetics | Genotype | Clinical Trials as Topic | Hepatitis C, Chronic - drug therapy | Genome, Human - genetics | Interferon alpha-2 | Polymorphism, Single Nucleotide - genetics | Genetic Variation - genetics | Interferon-alpha - adverse effects | Hepatitis C, Chronic - genetics | Demographic aspects | Development and progression | Genetic aspects | Hepatitis C | Hepatitis C virus | Identification and classification | Genetic polymorphisms | Confidence intervals | Hepatitis | Human immunodeficiency virus--HIV | African Americans | Infections | Drug therapy | Gene expression | Minority & ethnic groups | Index Medicus
Journal Article
Human genetics, ISSN 0340-6717, 06/2020, Volume 139, Issue 6-7, pp. 733 - 743
Life Sciences & Biomedicine | Genetics & Heredity | Science & Technology | Infants (Newborn) | Immune response | B cells | BCG | BCG vaccines | Diseases | Neonates | Infectious diseases | Newborn babies | Pathogenesis | Opportunist infection | Infections | Infants | Genetic diversity | Age | Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2001, Volume 358, Issue 9290, pp. 1322 - 1327
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | Medical sciences | Drug toxicity and drugs side effects treatment | Miscellaneous (drug allergy, mutagens, teratogens...) | Pharmacology. Drug treatments | Severity of Illness Index | Prevalence | Prospective Studies | Cross-Sectional Studies | Anti-HIV Agents - adverse effects | Humans | Middle Aged | Logistic Models | Male | Reverse Transcriptase Inhibitors - adverse effects | Switzerland - epidemiology | Adult | Female | Antiviral agents | Protease inhibitors | Adverse and side effects | HIV patients | Reverse transcriptase inhibitors | Drug therapy | HIV infection | Health aspects | Side effects | Human immunodeficiency virus | HIV | Index Medicus | Abridged Index Medicus
Journal Article
Hepatology (Baltimore, Md.), ISSN 0270-9139, 12/2010, Volume 52, Issue 6, pp. 1888 - 1896
Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Viral hepatitis | Infectious diseases | Liver. Biliary tract. Portal circulation. Exocrine pancreas | Viral diseases | Biological and medical sciences | Medical sciences | Human viral diseases | Interleukins - genetics | Signal Transduction | Humans | Middle Aged | Adult | Female | Male | MicroRNAs - biosynthesis | Interferons - physiology | Hepatitis C, Chronic - genetics | Viral Load | Hepatitis | Genotype & phenotype | Interferon | Biopsy | Index Medicus
Journal Article
ACM computing surveys, ISSN 0360-0300, 09/2015, Volume 48, Issue 1, pp. 1 - 44
recreational genomics | security | Genomics privacy | health care | biomedical research | Health care | Biomedical research | Security | Recreational genomics | Computer Science, Theory & Methods | Technology | Computer Science | Science & Technology | Privacy | Safety and security measures | Management | Nucleotide sequencing | Data security | DNA sequencing | Studies | Computer science | Data integrity | Genomics | Genetic testing | Biotechnology industry | Medicine | Forensic engineering | Medical services | Genomes | DNA testing | Public policy | Diseases | Additional Key Words and Phrases: genomics privacy | healthcare
Journal Article
The Lancet (British edition), ISSN 0140-6736, 01/2002, Volume 359, Issue 9300, pp. 30 - 36
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Antiviral agents | Biological and medical sciences | Medical sciences | Pharmacology. Drug treatments | Antibiotics. Antiinfectious agents. Antiparasitic agents | HIV-1 | Prospective Studies | Humans | Male | Benzoxazines | Chromatography, High Pressure Liquid | ATP-Binding Cassette, Sub-Family B, Member 1 - drug effects | Polymerase Chain Reaction | Anti-HIV Agents - therapeutic use | Female | Anti-HIV Agents - blood | Genes, MDR - drug effects | HIV Protease Inhibitors - blood | Nelfinavir - therapeutic use | Pharmacogenetics | Genotype | Logistic Models | Treatment Outcome | ATP-Binding Cassette, Sub-Family B, Member 1 - physiology | HIV Protease Inhibitors - therapeutic use | Nelfinavir - blood | Cytochrome P-450 Enzyme System - drug effects | Oxazines - therapeutic use | Alleles | Cytochrome P-450 Enzyme System - genetics | HIV Infections - drug therapy | Genes, MDR - genetics | Oxazines - blood | Physiological aspects | Highly active antiretroviral therapy | HIV patients | Genetic aspects | Glycoproteins | Medical research | Human immunodeficiency virus | HIV | Drug therapy | Genes | Cytochrome | Viremia | Drug resistance | Gene polymorphism | Recovery | Efavirenz | Immunosuppressive agents | Proteins | MDR1 protein | Immunology | Antiretroviral agents | Human immunodeficiency virus--HIV | Nelfinavir | Biocompatibility | P-Glycoprotein | CYP2D6 protein | Genotypes | Electrical impedance | Antiretroviral drugs | CCR5 protein | Isoenzymes | Multidrug resistance | Cytochrome P450 | Pharmacology | Patients | CD4 antigen | Gene amplification | Mutation | Transporter | Polymorphism | Index Medicus | Abridged Index Medicus
Journal Article
The Lancet infectious diseases, ISSN 1473-3099, 03/2018, Volume 18, Issue 3, pp. e64 - e75
Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | Tuberculosis - epidemiology | Genetic Predisposition to Disease | Pharmacogenetics | Tuberculosis - genetics | Drug Resistance, Multiple, Bacterial | Humans | Tuberculosis - drug therapy | Antitubercular Agents - pharmacology | Mycobacterium tuberculosis - drug effects | Medical research | Tuberculosis | Communicable diseases | Medicine, Experimental | Antitubercular agents | Genetic aspects | Disease susceptibility | Health aspects | Epidemics | Pandemics | Disease | Genomics | Infections | Genomes | Drug resistance | Drug development | Human populations | Hepatitis | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | DNA methylation | Genetics | Pharmacogenomics | Antigens | Bacterial infections | Dendritic cells | Medical treatment | Pharmacology | Gene expression | Disease control | Studies | Genetic variance | Lungs | Epigenetics | Chemokines | Genes | Virulence | Evolution | Pathogens | Granulomas | Index Medicus
Journal Article